Bill Welch
President and Founder of Welch Advisory, Inc

Is this your profile?

About

Bill Welch is President and Founder of Welch Advisory, Inc (Wisconsin, US) and serves as an advisor to Picocyl. With more than 20 years of experience in contract development and manufacturing focused on drug delivery and diagnostics products, he has worked across R&D, product development, quality, and operations leadership roles during his career.

Mr Welch founded his consultancy in early 2022, serving in advisor and board member roles to companies in the healthcare, product development and manufacturing space. Prior to that he served as Chief Technical Officer at Phillips-Medisize, where he led a global development, engineering, tooling, program management and validation organisation with more than 500 people and 75 concurrent schemes.

Contributions

ADVANCEMENTS AND EVOLUTION OF POWER SOURCES IN DRUG DELIVERY

William Welch considers the evolution of compressed gas alternatives to spring power for single-use drug delivery devices.

More contributions

BILL WELCH, PHILLIPS-MEDISIZE & JOHN PATTON, DANCE BIOPHARM

In this exclusive interview with ONdrugDelivery Magazine, Bill Welch and John Patton discuss inhaled insulin, connectivity and their two companies’ close partnership

PREFILLED SYRINGES

CRITICAL CONSIDERATIONS FOR HIGH VISCOSITY/HIGH VOLUME DEVICES

There are some device design considerations that are common across the spectrum of biologics development. Bill Welch discusses these considerations, highlighting the advantage conferred by accounting for them early in the product lifecycle.

THE PROMISE OF CONNECTED HEALTHCARE (AND WHY IT’S PROVING HARD TO GET THERE)

Kevin Deane and Bill Welch show that clear trends are emerging, some helping to push connected healthcare forward and some that are slowing down progress, and describe the opportunities and challenges arising.

BILL WELCH, PHILIPS-MEDISIZE

Mr Welch gives ONdrugDelivery Magazine an exclusive preview of Phillips-Medisize’s forthcoming workshop, “Realizing the Benefits of Connected Health in Respiratory Drug Delivery”.

SYSTEMS ENGINEERING FOR COMPLEX PORTABLE DRUG DELIVERY DEVICE DEVELOPMENT

Bill Welch explains how a systems-engineering approach provides an efficient method of developing smaller, smarter and more complex inhaler devices.

PREFILLED SYRINGES

THE POWER OF DRUG-DEVICE COMPANY COLLABORATION

During the Pharmapack Europe Conference (Paris, France) – at 4pm on Wednesday, February 10th, 2016 – Bill Welch, Chief Technology Officer, Phillips-Medisize Corporation, will give a lecture entitled “Integrated Development and Scale-Up of Combination Products”. Here, he provides us with a preview of his forthcoming Pharmapack talk.

HUMAN-CENTRED DESIGN & INHALATION DEVICE DEVELOPMENT

Bill Welch explains how the term “smaller and smarter” applies in the development of inhalation devices, and describes how his company’s human-centred design approach.

SCALABLE AUTOMATION FOR DRUG DELIVERY DEVICES

Bill Welch outlines why Phillips-Medisize provides a comprehensive assembly concept, tailored to customers’ needs.

HUMAN-CENTRED DESIGN AT THE HEART OF A SUCCESSFUL PRODUCT DEVELOPMENT PROCESS

Bill Welch and Jeremy Odegard provide an insight into how the company’s human centred design approach fits into its integrated product development process.

PREFILLED SYRINGES

COMPANY SHOWCASE: PHILLIPS-MEDISIZE

Phillips-Medisize is a global-leader in outsource design, development and technology-driven manufacturing.

Top